Metabolic syndrome affects nearly 40% of adults, with sharper increases seen in older age groups and non-Hispanic Black ...

Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, today announced results from the first independent validation of AidaBreasttm, a novel multi-omic ...

Discover how Dr. Manjiri Bakre's OncoStem Diagnostics is transforming early-stage breast cancer treatment with CanAssist-Breast, an AI-powered prognostic test that offers personalized risk predictions ...

Boston Scientific has obtained an approval in Europe for the latest addition to its pulsed field ablation portfolio, with the ...

Boston Scientific (NYSE: BSX) announced recently that it received CE mark for its Farapoint pulsed field ablation (PFA) ...

Celcuity has successfully transitioned from a speculative biotechnology company to a pre-commercial firm with a de-risked lead product. Read why CELC is a Buy.

Google Research has unveiled Titans, a neural architecture using test-time training to actively memorize data, achieving effective recall at 2 million tokens.

Background Recurrent mitral regurgitation (MR) remains a major limitation of mitral valve (MV) repair in patients with ...

Casey Murphy has fanned his passion for finance through years of writing about active trading, technical analysis, market commentary, exchange-traded funds (ETFs), commodities, futures, options, and ...

Actinium Pharmaceuticals, Inc. (NYSE American: ATNM), a leader in the development of differentiated targeted radiotherapies, today announced compelling preclinical data for ATNM-400, a first-in-class ...